Physician Wealth Advisors
STIM icon

Physician Wealth Advisors’s Neuronetics STIM Stock Holding History

Physician Wealth Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.81K Hold
775
– – ﹤0.01% 1634
2026
Q2 		$1.01K Hold
775
– – ﹤0.01% 1831
2026
Q1 		$1.12K Buy
+775
New +$1.23K ﹤0.01% 1612

Other funds holding STIM

T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
CH
Canton Hathaway Providence, Rhode Island $513M AUM 16.15% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Physician Wealth Advisors's STIM Position: Q3 2026 in Review

Physician Wealth Advisors held its Neuronetics (STIM) position steady in Q3 2026 at 775 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Physician Wealth Advisors first reported a position in STIM in Q1 2026 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Physician Wealth Advisors held 775 shares of Neuronetics worth $1.81K as of Q3 2026.
  • Physician Wealth Advisors left its Neuronetics share count unchanged in Q3 2026.
  • Neuronetics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1634 holding.
  • Physician Wealth Advisors first reported a position in Neuronetics in Q1 2026 and has held it in 3 quarters since.
  • 7 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.